Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.resp.2020.103476 http://scihub22266oqcxt.onion/10.1016/j.resp.2020.103476 32522574!7275159!32522574     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Respir+Physiol+Neurobiol 2020 ; 279 (ä): 103476 Nephropedia Template TP {{tp|p=32522574|t=2020. Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?|pdf=|usr=}}{{32522574}} gab.com Text Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19 JO: Respir Physiol Neurobiol http://www.kidney.de/pget.php?&tw=1&pmid=32522574 #FOAvip A very recent epidemiological study provides preliminary evidence that living in habitats located at 2500?m above sea level (masl) might protect from the development of severe respiratory symptoms following infection with the novel SARS-CoV-2 virus. This epidemiological finding raises the question of whether physiological mechanisms underlying the acclimatization to high altitude identifies therapeutic targets for the effective treatment of severe acute respiratory syndrome pivotal to the reduction of global mortality during the COVID-19 pandemic. This article compares the symptoms of acute mountain sickness (AMS) with those of SARS-CoV-2 infection and explores overlapping patho-physiological mechanisms of the respiratory system including impaired oxygen transport, pulmonary gas exchange and brainstem circuits controlling respiration. In this context, we also discuss the potential impact of SARS-CoV-2 infection on oxygen sensing in the carotid body. Finally, since erythropoietin (EPO) is an effective prophylactic treatment for AMS, this article reviews the potential benefits of implementing FDA-approved erythropoietin-based (EPO) drug therapies to counteract a variety of acute respiratory and non-respiratory (e.g. excessive inflammation of vascular beds) symptoms of SARS-CoV-2 infection. Twit Text FOAVip Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19 ????Respir Physiol Neurobiol http://www.kidney.de/pget.php?&tw=1&pmid=32522574 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32522574 #FOAvip English Wikipedia <ref>{{Cite pmid|32522574}}</ref> Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19? #MMPMID32522574 Soliz J; Schneider-Gasser EM; Arias-Reyes C; Aliaga-Raduan F; Poma-Machicao L; Zubieta-Calleja G; Furuya WI; Trevizan-Bau P; Dhingra RR; Dutschmann M Respir Physiol Neurobiol 2020[Aug]; 279 (ä): 103476 PMID32522574show ga A very recent epidemiological study provides preliminary evidence that living in habitats located at 2500?m above sea level (masl) might protect from the development of severe respiratory symptoms following infection with the novel SARS-CoV-2 virus. This epidemiological finding raises the question of whether physiological mechanisms underlying the acclimatization to high altitude identifies therapeutic targets for the effective treatment of severe acute respiratory syndrome pivotal to the reduction of global mortality during the COVID-19 pandemic. This article compares the symptoms of acute mountain sickness (AMS) with those of SARS-CoV-2 infection and explores overlapping patho-physiological mechanisms of the respiratory system including impaired oxygen transport, pulmonary gas exchange and brainstem circuits controlling respiration. In this context, we also discuss the potential impact of SARS-CoV-2 infection on oxygen sensing in the carotid body. Finally, since erythropoietin (EPO) is an effective prophylactic treatment for AMS, this article reviews the potential benefits of implementing FDA-approved erythropoietin-based (EPO) drug therapies to counteract a variety of acute respiratory and non-respiratory (e.g. excessive inflammation of vascular beds) symptoms of SARS-CoV-2 infection. |Acclimatization/*physiology[MESH] |Altitude Sickness/*physiopathology[MESH] |COVID-19[MESH] |Coronavirus Infections/*drug therapy/immunology/metabolism/*physiopathology[MESH] |Erythropoietin/*pharmacology[MESH] |Humans[MESH] |Hypoxia/*physiopathology[MESH] |Pandemics[MESH]Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treat(epmc).pdf DeepDyve Pubget Overpricing